Canada markets closed

TRxADE HEALTH, Inc. (MEDS)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
6.29+0.12 (+1.94%)
At close: 04:00PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
8,272
8,272
10,250
9,889
17,123
Cost of Revenue
5,674
5,674
4,731
5,143
11,415
Gross Profit
2,598
2,598
5,519
4,746
5,707
Operating Expenses
Research Development
1,377
1,377
993.185
899.705
-
Selling General and Administrative
8,485
8,485
6,567
7,536
7,488
Total Operating Expenses
9,862
9,862
7,560
8,435
7,488
Operating Income or Loss
-7,263
-7,263
-2,041
-3,690
-1,781
Interest Expense
1,198
1,198
336.206
23.59
29.389
Total Other Income/Expenses Net
-5,263
-5,263
-47.506
-1,603
-725.973
Income Before Tax
-13,721
-13,721
-2,403
-5,316
-2,536
Income from Continuing Operations
-13,721
-13,721
-2,403
-5,316
-2,536
Net Income
-17,844
-17,844
-3,472
-5,316
-2,536
Net Income available to common shareholders
-17,844
-17,844
-3,472
-5,316
-2,536
Basic EPS
-6.33
-23.35
-6.15
-9.75
-4.95
Diluted EPS
-6.33
-23.35
-6.15
-9.75
-4.95
Basic Average Shares
629.782
764.058
564.862
542.449
513.708
Diluted Average Shares
629.782
2,381
566.609
542.449
513.708